Topical nepafenac after intravitreal injection: a prospective double-masked randomized controlled trial.
Ulrich JN.
Retina · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/iae.0b013e3182a0e611 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för nepafenac. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarNepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
Jones BM, Neville MW.
Ann Pharmacother · review; journal article · DOI 10.1345/aph.1r757Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.
Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D.
Clin Ophthalmol · research-article; journal article · DOI 10.2147/opth.s31902Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.
Naithani P, Puranik S, Vashisht N, Khanduja S, Kumar S, Garg S.
Retina · comparative study; randomized controlled trial; journal article · DOI 10.1097/iae.0b013e31821e2057Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients.
Numaga J.
J Ophthalmic Inflamm Infect · research-article; journal article · DOI 10.1007/s12348-011-0036-8Nepafenac-assisted mydriasis in a rabbit model.
Yoon MK, Naseri A, Porco T, McLeod SD.
J Cataract Refract Surg · comparative study; journal article · DOI 10.1016/j.jcrs.2010.04.033Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
Lindstrom R, Kim T.
Curr Med Res Opin · research support, non-u.s. gov't; review; journal article · DOI 10.1185/030079906x89775New drugs: ramelteon, tipranavir, nepafenac, and deferasirox.
Hussar DA.
J Am Pharm Assoc (2003) · review; journal article · DOI 10.1331/154434506775268643Nepafenac: a unique nonsteroidal prodrug.
Lane SS.
Int Ophthalmol Clin · review; journal article · DOI 10.1097/01.iio.0000212129.53019.49Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.
Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM.
Inflammation · comparative study; journal article · DOI 10.1023/a:1007049015148Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
Ke TL, Graff G, Spellman JM, Yanni JM.
Inflammation · journal article · DOI 10.1023/a:1007001131987